Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$436M |
| 2 |
United Therapeutics
UTHR
|
+$393M |
| 3 |
Amazon
AMZN
|
+$376M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$372M |
| 5 |
Visa
V
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$313M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$272M |
| 3 |
Stellantis
STLA
|
+$222M |
| 4 |
TSMC
TSM
|
+$215M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Consumer Discretionary | 6.77% |
| 3 | Healthcare | 6.2% |
| 4 | Financials | 5.48% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
CALL
AnaptysBio
ANAB
$1.54B
| $601K | ﹤0.01% |
24,000
-6,000
| -20% | -$140K |
|
|
3152
PUT
AnaptysBio
ANAB
$1.54B
| $601K | ﹤0.01% |
24,000
-6,000
| -20% | -$140K |
|
3153
Hillman Solutions
HLMN
$1.57B
| $601K | ﹤0.01% |
67,881
+8,000
| +13% | +$75.4K |
|
3154
Burford Capital
BUR
$914M
| $601K | ﹤0.01% |
46,591
-268,350
| -85% | -$3.94M |
|
3155
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.26B
| $601K | ﹤0.01% |
4,903
+837
| +21% | +$101K |
|
3156
Byline Bancorp
BY
$1.78B
| $598K | ﹤0.01% |
25,172
+1,395
| +6% | +$31K |
|
3157
TechTarget
TTGT
$327M
| $595K | ﹤0.01% |
19,083
+1,491
| +8% | +$44.3K |
|
|
INN
3158
Summit Hotel Properties
INN
$766M
| $594K | ﹤0.01% |
99,234
+2,700
| +3% | +$16.5K |
|
3159
Koppers
KOP
$946M
| $594K | ﹤0.01% |
16,058
+1,121
| +8% | +$52.3K |
|
3160
Aurora
AUR
$11.7B
| $593K | ﹤0.01% |
214,056
+87,180
| +69% | +$241K |
|
3161
CALL
Zoom
ZM
$27.1B
| $592K | ﹤0.01% |
+10,000
| New | +$614K |
|
|
3162
PUT
Zoom
ZM
$27.1B
| $592K | ﹤0.01% |
+10,000
| New | +$614K |
|
3163
V2X
VVX
$2.7B
| $591K | ﹤0.01% |
12,330
-1,619
| -12% | -$76.7K |
|
|
METD
3164
Direxion Daily META Bear 1X ETF
METD
$8.68M
| $590K | ﹤0.01% |
+25,000
| New | +$592K |
|
3165
Timken Company
TKR
$9.19B
| $587K | ﹤0.01% |
7,326
-334
| -4% | -$28.8K |
|
3166
CALL
Beam Therapeutics
BEAM
$2.68B
| $586K | ﹤0.01% |
25,000
-24,900
| -50% | -$612K |
|
|
3167
PUT
Beam Therapeutics
BEAM
$2.68B
| $586K | ﹤0.01% |
25,000
-24,900
| -50% | -$612K |
|
|
OSG
3168
Octave Specialty Group
OSG
$257M
| $586K | ﹤0.01% |
45,677
+14,677
| +47% | +$224K |
|
3169
Kymera Therapeutics
KYMR
$8.66B
| $585K | ﹤0.01% |
19,586
-201,325
| -91% | -$6.97M |
|
3170
Bristow Group
VTOL
$1.33B
| $585K | ﹤0.01% |
17,434
+1,118
| +7% | +$34.6K |
|
|
MORF
3171
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $583K | ﹤0.01% |
17,122
-173,223
| -91% | -$5.13M |
|
3172
Riot Platforms
RIOT
$6.9B
| $583K | ﹤0.01% |
63,778
-30,523
| -32% | -$308K |
|
3173
Darling Ingredients
DAR
$9.32B
| $582K | ﹤0.01% |
15,838
-109,349
| -87% | -$4.54M |
|
3174
Genmab
GMAB
$17.5B
| $580K | ﹤0.01% |
23,069
+4,489
| +24% | +$127K |
|
|
SHOE
3175
Shoe Station Group
SHOE
$424M
| $580K | ﹤0.01% |
15,714
+2,390
| +18% | +$84.9K |
|
Similar funds
Citigroup's Q2 2024 Portfolio in Review
As of Q2 2024, Citigroup held 5,888 positions worth $156B, up 2.5% from $152B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup's Q2 2024 filing shows 274 new, 2,819 increased, 1,798 reduced and 330 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M. The largest sale was iShares MSCI EAFE ETF, an estimated $313M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Citigroup's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M.
- Citigroup added most to Intel in Q2 2024, an estimated $436M increase.
- Citigroup's biggest Q2 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $313M.
- Citigroup fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $79.7M.
- Citigroup's ten largest holdings make up 22% of its $156B portfolio in Q2 2024.
- Citigroup opened 274 new positions and closed 330 in Q2 2024.
- Citigroup's portfolio value rose 2.5% quarter-over-quarter to $156B.
Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.